期刊
CANCER CELL
卷 17, 期 2, 页码 186-197出版社
CELL PRESS
DOI: 10.1016/j.ccr.2009.12.045
关键词
-
资金
- Ministry of Science and Technology of China [2006CB910405, 2006CB910700, 2007AA02Z335, 2006AA02Z302, 2009CB825607]
- National Natural Science Foundation [30730033, 30670436, 30600260]
- Chinese Academy of Sciences [KSCX2-YW-R-19, GJHZ06]
- Shanghai Commission of Science and Technology [07SP07002]
- European Community [200973]
- Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish
- BBSRC [BB/G022771/1] Funding Source: UKRI
PML/RAR alpha is of crucial importance in acute promyelocytic leukemia (APL) both pathologically and therapeutically. Using a genome-wide approach, we identified in vivo PML/RAR alpha binding sites in a PML/RAR alpha-inducible cell model. Of the 2979 targeted regions, >62% contained canonical PU.1 motifs and >84% of these PU.1 motifs coexisted with one or more RARE half (RAREh) sites in nearby regions. Promoters with such PU.1-RAREh binding sites were transactivated by PU.1. PU.1-mediated transactivation was repressed by PML/RAR alpha and restored by the addition of all-trans retinoic acid (ATRA). Genes containing such promoters were significantly represented by genes transcriptionally suppressed in APL and/or reactivated upon treatment with ATRA. Thus, selective targeting of PU.1-regulated genes by PML/RAR alpha is a critical mechanism for the pathogenesis of APL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据